Alessandro Blasimme holds an MA in bioethics from La Sapienza University of Rome (Italy), as well as a PhD in bioethics from the University of Milan – European School of Molecular Medicine (Italy). He has held research appointments at the French National Institute of Health and Medical Research (INSERM) as well as the University of Zürich (Switzerland), before joining the Swiss Federal Institute of Technology (ETH Zürich) as a senior researcher in bioethics in 2017. In 2013 he received a Fulbright-Schuman Scholarship to undertake research at the Program on Science, Technology and Society, Harvard University (USA) where he was a fellow. His research focuses on ethical and policy issues in biomedical innovation and biotechnology. His areas of expertise include translational medicine, precision medicine, regenerative medicine, genetic engineering, digital health and ageing. He has published widely in leading bioethics and medical journals and he is principal investigator in large European research consortia. He is currently a guest editor for a special issue (December 2019) on genome editing of the American Medical Association’s Journal of Ethics.